Drug-induced Cushing Syndrome in a Patient With Ulcerative Colitis After Betamethasone Enema: Evaluation of Plasma Drug Concentration
- 1 August 1998
- journal article
- case report
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 20 (4) , 387-389
- https://doi.org/10.1097/00007691-199808000-00006
Abstract
The authors report the induction of Cushing syndrome by daily betamethasone enema in a patient with ulcerative colitis, and they determine for the first time the pharmacokinetic profile of betamethasone after rectal dosing. The authors found high plasma concentrations of betamethasone, which could have been enough to cause Cushing syndrome. Suppression of the hypothalamus-pituitary-adrenal axis disappeared after the dose schedule was changed from every day to three times a week. These findings suggest that a considerable amount of betamethasone is absorbed after rectal dosing.Keywords
This publication has 5 references indexed in Scilit:
- Rectal pharmacokinetics of budesonideEuropean Journal of Clinical Pharmacology, 1996
- Plasma concentrations of betamethasone after topical application of betamethasone 17‐valerate: comparison with oral administration.British Journal of Clinical Pharmacology, 1994
- Adrenal Cortical and Pituitary Function after Intrarectal Steroid TherapyBMJ, 1963
- Betamethasone enemata in ulcerative colitisGut, 1962
- Treatment of Ulcerative Colitis with Local HydrocortisoneBMJ, 1956